OESOPHAGEAL MUCOSA ERYTHEMA

OESOPHAGEAL MUCOSA ERYTHEMA was reported 42 times

OESOPHAGEAL MUCOSA ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 3 0.0001
1 Fluoroquinolone Antibacterial [EPC] 8 0.0001
2 Orexin Receptor Antagonist [EPC] 1 0.0001
3 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
4 Muscle Relaxant [EPC] 2 0.0000
5 Opioid Agonist [EPC] 11 0.0000
6 Interleukin-17A Antagonist [EPC] 1 0.0000
7 Nucleoside Analog Antiviral [EPC] 2 0.0000
8 Nitrate Vasodilator [EPC] 2 0.0000
9 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
10 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
11 Sulfonylurea [EPC] 2 0.0000
12 HMG-CoA Reductase Inhibitor [EPC] 6 0.0000
13 Androgen Receptor Inhibitor [EPC] 1 0.0000
14 Proton Pump Inhibitor [EPC] 7 0.0000
15 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
16 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
17 Insulin Analog [EPC] 4 0.0000
18 Aromatase Inhibitor [EPC] 1 0.0000
19 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
20 Alkylating Drug [EPC] 2 0.0000
21 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
22 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
23 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
24 Janus Kinase Inhibitor [EPC] 1 0.0000
25 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
26 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
27 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
28 GLP-1 Receptor Agonist [EPC] 2 0.0000
29 Atypical Antipsychotic [EPC] 2 0.0000
30 Thalidomide Analog [EPC] 2 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Factor Xa Inhibitor [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Benzodiazepine [EPC] 2 0.0000
35 Vitamin C [EPC] 1 0.0000
36 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 1 0.0000
39 Corticosteroid [EPC] 2 0.0000
40 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000